ID24528A - Komposisi-komposisi obat farmasi yang mengandung eletriptan hemisulfat dan kafein - Google Patents

Komposisi-komposisi obat farmasi yang mengandung eletriptan hemisulfat dan kafein

Info

Publication number: ID24528A
Authority: ID; Indonesia
Prior art keywords: hemisulfate; electryptants; cafein; compositions; pct
Prior art date: 1997-07-03

Application number

IDW991585A

Other languages

English (en)

Indonesian (id)

Inventor

Valerie Denise Harding

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-03

Filing date

1998-07-01

Publication date

2000-07-20

1997-07-03 Priority claimed from GBGB9714081.8A external-priority patent/GB9714081D0/en

1998-07-01 Application filed by Pfizer filed Critical Pfizer

2000-07-20 Publication of ID24528A publication Critical patent/ID24528A/id

Links

229940079593 drug Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
IYVZCNNIKYUHHM-WXMGBDCWSA-N OS(O)(=O)=O.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1 Chemical compound OS(O)(=O)=O.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1 IYVZCNNIKYUHHM-WXMGBDCWSA-N 0.000 abstract 1
229960001948 caffeine Drugs 0.000 abstract 1
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IDW991585A 1997-07-03 1998-07-01 Komposisi-komposisi obat farmasi yang mengandung eletriptan hemisulfat dan kafein ID24528A (id)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9714081.8A GB9714081D0 (en)	1997-07-03	1997-07-03	Pharmaceutical compositions
GBGB9718270.3A GB9718270D0 (en)	1997-07-03	1997-08-28	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
ID24528A true ID24528A (id)	2000-07-20

Family

ID=26311826

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW991585A ID24528A (id)	1997-07-03	1998-07-01	Komposisi-komposisi obat farmasi yang mengandung eletriptan hemisulfat dan kafein

Country Status (30)

Country	Link
US (1)	US6166025A (de)
EP (1)	EP0999841B1 (de)
JP (1)	JP3350061B2 (de)
CN (1)	CN1145486C (de)
AT (1)	ATE206921T1 (de)
AU (1)	AU724728B2 (de)
BG (1)	BG103930A (de)
BR (1)	BR9810658A (de)
CA (1)	CA2292673C (de)
DE (1)	DE69802097T2 (de)
DK (1)	DK0999841T3 (de)
DZ (1)	DZ2549A1 (de)
EA (1)	EA002174B1 (de)
ES (1)	ES2163291T3 (de)
HR (1)	HRP990416B1 (de)
HU (1)	HUP0004468A3 (de)
ID (1)	ID24528A (de)
IL (1)	IL133206A0 (de)
IS (1)	IS5283A (de)
MA (1)	MA26518A1 (de)
NO (1)	NO312993B1 (de)
NZ (1)	NZ501419A (de)
OA (1)	OA11227A (de)
PL (1)	PL337803A1 (de)
PT (1)	PT999841E (de)
SI (1)	SI0999841T1 (de)
SK (1)	SK284462B6 (de)
TR (1)	TR199903332T2 (de)
UY (1)	UY25078A1 (de)
WO (1)	WO1999001135A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9816556D0 (en) *	1998-07-30	1998-09-30	Pfizer Ltd	Therapy
GB9825988D0 (en)	1998-11-27	1999-01-20	Pfizer Ltd	Indole derivatives
GB9922963D0 (en) *	1999-09-28	1999-12-01	Pfizer Ltd	Polymorphic salt
US6500834B1 (en)	1999-04-27	2002-12-31	Board Of Regents, The University Of Texas System	Composition and method for treatment of cerebral ischemia
GB9915231D0 (en)	1999-06-29	1999-09-01	Pfizer Ltd	Pharmaceutical complex
CO5190678A1 (es) *	1999-06-30	2002-08-29	Pfizer Prod Inc	Terapia combinada para el tratamiento de la migrana
CO5190664A1 (es) *	1999-06-30	2002-08-29	Pfizer Prod Inc	Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
IL136961A0 (en) *	1999-06-30	2001-06-14	Pfizer Prod Inc	5ht1 receptor agonists, caffeine and either a cox-2 inhibitor or nsaid for the treatment of migraine
GB9923314D0 (en)	1999-10-01	1999-12-08	Pfizer Ltd	Acylation process
US6579898B2 (en) *	2001-03-01	2003-06-17	Pfizer Inc.	Compositions having improved bioavailability
WO2003020977A2 (en) *	2001-08-31	2003-03-13	The University Court Of The University Of Glasgow	Nucleotide repeats assay
US7404489B1 (en)	2003-03-04	2008-07-29	Qol Medical, Llc	Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
GB0312478D0 (en) *	2003-05-30	2003-07-09	Pfizer Ltd	Improved process
US7132549B2 (en)	2003-05-30	2006-11-07	Pfizer Inc.	Process
GB2407498B (en) *	2003-10-30	2008-06-11	Cipla Ltd	Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
US20080286388A1 (en) *	2004-10-22	2008-11-20	Shin-Jen Shiao	Pharmaceutical Composition and Non Dependence Coffee Comprising Edible Carboxylic Acid and/or Its Acid Salts and Coffeine
US8506934B2 (en)	2005-04-29	2013-08-13	Robert I. Henkin	Methods for detection of biological substances
WO2007022345A2 (en) *	2005-08-17	2007-02-22	Fleming And Company, Pharmaceuticals	Vitamin b12 nasal spray and method of use
US20070041905A1 (en) *	2005-08-19	2007-02-22	Hoffman Rebecca S	Method of treating depression using a TNF-alpha antibody
WO2008095136A2 (en)	2007-01-31	2008-08-07	Henkin Robert I	Methods for detection of biological substances
FR2926721B1 (fr) *	2008-01-30	2011-07-22	Philippe Perovitch	Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
US8580801B2 (en)	2008-07-23	2013-11-12	Robert I. Henkin	Phosphodiesterase inhibitor treatment
JP5776355B2 (ja) *	2010-07-16	2015-09-09	大正製薬株式会社	内服液剤
US8915245B2 (en) *	2010-10-07	2014-12-23	Vapotherm, Inc.	Nebulizer systems, apparatus and methods for respiratory therapy
JP5887893B2 (ja) *	2010-12-10	2016-03-16	大正製薬株式会社	内服液剤
JP5887894B2 (ja) *	2010-12-10	2016-03-16	大正製薬株式会社	内服液剤
ES2744542T3 (es) *	2013-03-15	2020-02-25	Robert I Henkin	Inhibidores de fosfodiesterasa para tratar trastornos gustativos y olfativos
EP3488889A1 (de)	2013-08-08	2019-05-29	Vapotherm, Inc.	Kondensationsadapter für atemtherapien
NL1040474C2 (en) *	2013-10-31	2015-05-04	Veramed B V	Nasal compositions stimulating ciliary activity.
US10598672B2 (en)	2014-02-18	2020-03-24	Cyrano Therapeutics, Inc.	Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
JP6097787B2 (ja) *	2015-06-09	2017-03-15	パルファーマシューティカル，インコーポレーテッド	鼻内送達用シアノコバラミン低粘度水性製剤
FR3053334B1 (fr) *	2016-06-30	2018-07-27	L'oreal	Melange liquide contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et de compose de xanthine
JP7606530B2 (ja)	2020-03-24	2024-12-25	シラノセラピューティクス，インコーポレイテッド	コロナウイルス感染症による化学感覚機能障害の治療
US12338189B2 (en) *	2023-05-24	2025-06-24	Defuse Technologies, LLC	Desensitized fertilizer compositions and methods of making same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9417310D0 (en) *	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents

1998
- 1998-07-01 HU HU0004468A patent/HUP0004468A3/hu unknown
- 1998-07-01 EA EA199901100A patent/EA002174B1/ru not_active IP Right Cessation
- 1998-07-01 DE DE69802097T patent/DE69802097T2/de not_active Expired - Fee Related
- 1998-07-01 AT AT98940152T patent/ATE206921T1/de not_active IP Right Cessation
- 1998-07-01 US US09/402,239 patent/US6166025A/en not_active Expired - Fee Related
- 1998-07-01 SI SI9830068T patent/SI0999841T1/xx unknown
- 1998-07-01 SK SK1828-99A patent/SK284462B6/sk unknown
- 1998-07-01 NZ NZ501419A patent/NZ501419A/xx unknown
- 1998-07-01 IL IL13320698A patent/IL133206A0/xx unknown
- 1998-07-01 ID IDW991585A patent/ID24528A/id unknown
- 1998-07-01 AU AU88569/98A patent/AU724728B2/en not_active Ceased
- 1998-07-01 UY UY25078A patent/UY25078A1/es not_active IP Right Cessation
- 1998-07-01 HR HR970276A patent/HRP990416B1/xx not_active IP Right Cessation
- 1998-07-01 BR BR9810658-9A patent/BR9810658A/pt not_active Application Discontinuation
- 1998-07-01 ES ES98940152T patent/ES2163291T3/es not_active Expired - Lifetime
- 1998-07-01 DK DK98940152T patent/DK0999841T3/da active
- 1998-07-01 DZ DZ980159A patent/DZ2549A1/xx active
- 1998-07-01 PL PL98337803A patent/PL337803A1/xx unknown
- 1998-07-01 EP EP98940152A patent/EP0999841B1/de not_active Expired - Lifetime
- 1998-07-01 JP JP50638199A patent/JP3350061B2/ja not_active Expired - Fee Related
- 1998-07-01 PT PT98940152T patent/PT999841E/pt unknown
- 1998-07-01 MA MA25150A patent/MA26518A1/fr unknown
- 1998-07-01 CA CA002292673A patent/CA2292673C/en not_active Expired - Fee Related
- 1998-07-01 TR TR1999/03332T patent/TR199903332T2/xx unknown
- 1998-07-01 WO PCT/EP1998/004176 patent/WO1999001135A1/en not_active Ceased
- 1998-07-01 CN CNB988066289A patent/CN1145486C/zh not_active Expired - Fee Related
1999
- 1999-11-30 IS IS5283A patent/IS5283A/is unknown
- 1999-11-30 BG BG103930A patent/BG103930A/xx unknown
- 1999-12-01 NO NO19995887A patent/NO312993B1/no unknown
- 1999-12-03 OA OA9900271A patent/OA11227A/en unknown

Also Published As

Publication number	Publication date
DZ2549A1 (fr)	2003-02-08
TR199903332T2 (xx)	2000-09-21
DK0999841T3 (da)	2001-11-19
PT999841E (pt)	2002-02-28
EP0999841A1 (de)	2000-05-17
BR9810658A (pt)	2000-10-03
AU724728B2 (en)	2000-09-28
JP2000516262A (ja)	2000-12-05
CN1261279A (zh)	2000-07-26
HK1029282A1 (en)	2001-03-30
EA199901100A1 (ru)	2000-08-28
US6166025A (en)	2000-12-26
OA11227A (en)	2003-07-18
JP3350061B2 (ja)	2002-11-25
PL337803A1 (en)	2000-09-11
DE69802097T2 (de)	2002-03-14
IS5283A (is)	1999-11-30
IL133206A0 (en)	2001-03-19
EP0999841B1 (de)	2001-10-17
UY25078A1 (es)	2000-12-29
NZ501419A (en)	2000-09-29
HUP0004468A2 (hu)	2001-10-28
HUP0004468A3 (en)	2004-07-28
WO1999001135A1 (en)	1999-01-14
BG103930A (en)	2000-07-31
EA002174B1 (ru)	2002-02-28
DE69802097D1 (de)	2001-11-22
ES2163291T3 (es)	2002-01-16
HRP990416A2 (en)	2000-04-30
AU8856998A (en)	1999-01-25
NO995887L (no)	2000-03-02
SK284462B6 (sk)	2005-04-01
ATE206921T1 (de)	2001-11-15
CN1145486C (zh)	2004-04-14
MA26518A1 (fr)	2004-12-20
NO995887D0 (no)	1999-12-01
HRP990416B1 (en)	2002-04-30
CA2292673C (en)	2003-04-22
NO312993B1 (no)	2002-07-29
SI0999841T1 (de)	2001-12-31
SK182899A3 (en)	2000-09-12
CA2292673A1 (en)	1999-01-14

Publication	Publication Date	Title
ID24528A (id)	2000-07-20	Komposisi-komposisi obat farmasi yang mengandung eletriptan hemisulfat dan kafein
IL133825A0 (en)	2001-04-30	Substituted 6-phenylphenanthridines, medicaments containing same and use thereof
DE69727922D1 (de)	2004-04-08	Schnell zerfallende orale dosierungsform
HUT73807A (en)	1996-09-30	5-ht1-like indole derivatives and pharmaceutical compositions containing them
IL149163A0 (en)	2002-11-10	Piperazine derivatives of carbazole, their preparation and pharmaceutical compositions containing them
PL337794A1 (en)	2000-09-11	Pharmaceutic agent for oral administration containing an active substance and cyclodextrin
MX9707431A (es)	1997-12-31	Inhibidores de la proteina cinasa c.
ATE310738T1 (de)	2005-12-15	Gesättigte 1,2-dithiaheterocyclische verbindungen enthaltende antivirale pharmazeutische zubereitungen
SI0989851T1 (en)	2003-04-30	Self-emulsifying formulation for acidic lipophilic compounds
IL108234A0 (en)	1994-04-12	Pharmaceutical composition containing galanthamine
TNSN04034A1 (en)	2006-06-01	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
IT1314185B1 (it)	2002-12-06	Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
FR2763592B1 (fr)	1999-07-16	Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
AU3777197A (en)	1998-02-25	Cyclosporin formulation
FR2700166B1 (fr)	1995-02-17	Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
GEP20043377B (en)	2004-04-13	Pharmaceutical Complex
DE69318715D1 (de)	1998-06-25	Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
AU2001237768A1 (en)	2001-09-12	Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
MY119643A (en)	2005-06-30	Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
ECSP982578A (es)	1999-02-11	Composiciones farmaceuticas que contienen eletriptan hemisulfato
AU1388201A (en)	2001-05-08	Ruthenium (ii) complexes with high antitumoral and antimetastatic activities
MY152490A (en)	2014-10-15	New oral formulation